Patent ductus arteriosus: lack of evidence for common treatments

CL Bose, MM Laughon - Archives of Disease in Childhood-Fetal and …, 2007 - fn.bmj.com
Patent ductus arteriosus (PDA) is a common diagnosis among extremely premature infants,
especially in those with lung disease. Treatments are often used to close the PDA. Despite …

Bronchopulmonary dysplasia and inflammatory biomarkers in the premature neonate

CL Bose, CEL Dammann, MM Laughon - Archives of Disease in …, 2008 - fn.bmj.com
Bronchopulmonary dysplasia (BPD) is the most common, serious sequela of premature
birth. Inflammation is a major contributor to the pathogenesis of BPD. Often initiated by a …

Patency of the ductus arteriosus in the premature infant: is it pathologic? Should it be treated?

MM Laughon, MA Simmons… - Current opinion in …, 2004 - journals.lww.com
In preterm infants, patency of the ductus arteriosus may represent a normal physiologic
adaptation to allow shunting from either systemic-to-pulmonary circulation (eg, in the first …

Prediction of bronchopulmonary dysplasia by postnatal age in extremely premature infants

MM Laughon, JC Langer, CL Bose… - American journal of …, 2011 - atsjournals.org
Rationale: Benefits of identifying risk factors for bronchopulmonary dysplasia in extremely
premature infants include providing prognostic information, identifying infants likely to …

[HTML][HTML] Early inhaled nitric oxide therapy in premature newborns with respiratory failure

JP Kinsella, GR Cutter, WF Walsh… - … England Journal of …, 2006 - Mass Medical Soc
Background The safety and efficacy of early, low-dose, prolonged therapy with inhaled nitric
oxide in premature newborns with respiratory failure are uncertain. Methods We performed a …

Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled …

MK Hoffman, SS Goudar, BS Kodkany, M Metgud… - The Lancet, 2020 - thelancet.com
Background Preterm birth remains a common cause of neonatal mortality, with a
disproportionately high burden in low-income and middle-income countries. Meta-analyses …

Risk factors for chronic lung disease in the surfactant era: a North Carolina population-based study of very low birth weight infants

DD Marshall, M Kotelchuck, TE Young, CL Bose… - …, 1999 - publications.aap.org
Objective. To identify risk factors for chronic lung disease (CLD) in a population-based
cohort of very low birth weight infants, born in an era of surfactant usage. We specifically …

[HTML][HTML] Newborn-care training and perinatal mortality in developing countries

WA Carlo, SS Goudar, I Jehan, E Chomba… - … England Journal of …, 2010 - Mass Medical Soc
Background Of the 3.7 million neonatal deaths and 3.3 million stillbirths each year, 98%
occur in developing countries. An evaluation of community-based interventions designed to …

Fetal growth restriction and chronic lung disease among infants born before the 28th week of gestation

C Bose, LJ Van Marter, M Laughon, TM O'Shea… - …, 2009 - publications.aap.org
OBJECTIVE: Improvement in survival of extremely premature infants over the past several
decades has resulted in an increase in the number of infants with chronic lung disease …

Very early surfactant without mandatory ventilation in premature infants treated with early continuous positive airway pressure: a randomized, controlled trial

MA Rojas, JM Lozano, MX Rojas, M Laughon… - …, 2009 - publications.aap.org
BACKGROUND. Chronic lung disease is one of the most frequent and serious complications
of premature birth. Because mechanical ventilation is a major risk factor for chronic lung …